Abstract: A system and a method for identifying a non-switching semiconductor switch are proposed. The system has a first acquisition component, a second acquisition component and a determination unit. The first acquisition component is designed to acquire a profile of an electrical variable of a first semiconductor switch driven by way of a first drive signal. The second acquisition component is designed to acquire a profile of an electrical variable of a second semiconductor switch driven by way of a second drive signal and connected in parallel with the first semiconductor switch. The determination unit is designed to use the profile of the electrical variable of the first semiconductor switch and the profile of the electrical variable of the second semiconductor switch as a basis for determining an output signal that allows identification of a non-switching semiconductor switch for the first semiconductor switch and/or the second semiconductor switch.

Abstract: The present disclosure relates to use of reversal agents which specifically bind to anti-Natriuretic Peptide Receptor 1 (NPR1) antibodies or antigen binding fragments thereof, and reverse one or more effects of the anti-NPR1 antibody or antigen binding fragments thereof (e.g., hypotensive effects).

Abstract: The present invention relates to methods of increasing the cold tolerance of a plant or part thereof and/or preventing or inhibiting bolting of a plant, comprising deregulating phloem flux and plants or parts thereof having deregulated phloem flux. The invention also extends to the use of genes for deregulating phloem flux in a plant or part thereof; and/or increasing cold tolerance of a plant or part thereof; and/or preventing or inhibiting bolting in a plant. The invention also provides methods of selecting and/or producing a plant with deregulated phloem flux and/or increased cold tolerance and/or delayed or inhibited bolting. The invention also extends to constructs, isolated polynucleotides and polypeptides which can be used to deregulate phloem flux, plant cells transformed with such constructs, and to plants or parts thereof having deregulated phloem flux.

Abstract: The present invention is directed to a transgenic maize plant or a part thereof comprising as transgene a nucleic acid capable of expressing a cell wall invertase or a functional part thereof, preferably a Chenopodium rubrum cell wall invertase or a functional part thereof, wherein as a result of the expression of the cell wall invertase or a functional part thereof the transgenic maize plant exhibits an enhanced tolerance to abiotic stress and/or an increased yield, to a method of producing such transgenic maize plant, to method of enhancing the tolerance to abiotic stress of a maize plant and/or of increasing yield potential of a maize plant, to a nucleic acid capable of expressing a cell wall invertase or a functional part thereof, preferably a Chenopodium rubrum cell wall invertase or a functional part thereof, to a vector comprising such nucleic acid, the use of the nucleic acid or vector for enhancing the tolerance to abiotic stress of a maize plant, for increasing yield potential of a maize plant and/o

Abstract: The invention relates to a system (30) and a method for identifying a non-switching semiconductor switch (34a, 36a). The system (30) comprises a first semiconductor switch (34a), a first semiconductor component (34b), a second semiconductor switch (36a), a second semiconductor component (36b), a first resistor (64b), a second resistor (66b) and a detection unit (38). The detection unit (38) is designed to identify, on the basis of a curve of a first voltage dropping across the first resistor (64b), whether the first semiconductor switch (34a) is not switching. The detection unit (38) is designed to identify, on the basis of a curve of a second voltage dropping across the second resistor (66b), whether the second semiconductor switch (36a) is not switching.

Abstract: The present invention is directed to a transgenic maize plant or a part thereof comprising as transgene a nucleic acid capable of expressing a cell wall invertase or a functional part thereof, preferably a Chenopodium rubrum cell wall invertase or a functional part thereof, wherein as a result of the expression of the cell wall invertase or a functional part thereof the transgenic maize plant exhibits an enhanced tolerance to abiotic stress and/or an increased yield, to a method of producing such transgenic maize plant, to method of enhancing the tolerance to abiotic stress of a maize plant and/or of increasing yield potential of a maize plant, to a nucleic acid capable of expressing a cell wall invertase or a functional part thereof, preferably a Chenopodium rubrum cell wall invertase or a functional part thereof, to a vector comprising such nucleic acid, the use of the nucleic acid or vector for enhancing the tolerance to abiotic stress of a maize plant, for increasing yield potential of a maize plant and/o

Abstract: The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI (“Factor XIa”), and pharmaceutical compositions and methods of treatment comprising the same.

Abstract: The present disclosure relates to reversal agents, which specifically bind to anti-Factor XI and/or anti-Factor XIa antibodies (e.g., NOV1401), and reverse one or more anticoagulant effects of the anti-Factor XI and/or anti-Factor XIa antibodies (e.g., NOV1401), as well as to methods of use thereof, such as methods for reversing anticoagulant effects of such anti-Factor XI and/or anti-Factor XIa antibodies (e.g., NOV1401), and to related methods for managing bleeding or bleeding risks.

Abstract: The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI (“Factor XIa”), and pharmaceutical compositions and methods of treatment comprising the same.

Abstract: The invention relates to tonoplast proton/sugar antiporter proteins, more particularly tonoplast proton/saccharose antiporter proteins, the nucleotide sequences which encode them and uses thereof for producing transgenic plants with an increased saccharose concentration. The invention also includes methods for producing transgenic plants with an increased saccharose concentration, methods for increasing the saccharose concentration in plants, and for identifying plants which are suitable for creating a higher saccharose concentration.

Abstract: The invention relates to tonoplast proton/sugar antiporter proteins, more particularly tonoplast proton/saccharose antiporter proteins, the nucleotide sequences which encode them and uses thereof for producing transgenic plants with an increased saccharose concentration. The invention also includes methods for producing transgenic plants with an increased saccharose concentration, methods for increasing the saccharose concentration in plants, and for identifying plants which are suitable for creating a higher saccharose concentration.

Abstract: The present invention relates to the field of plant breeding and in particular to the generation of plants from cells and other tissues. More particularly, the invention provides methods and means for improving plant regeneration, especially from transformed or genetically modified plant cells.

Abstract: A transmitter is configured to transmit at least one signal with a pilot sequence having a plurality of pilot symbols, wherein the transmitter has a signal generator, wherein the signal generator provides the pilot sequence, wherein the signal generator provides the pilot sequence such that the pilot sequence has at least two symbol groups each having at least two pilot symbols, and the symbol groups, when evaluating a signal received by a receiver as a result of the transmission of the signal with respect to a phase, the symbol groups generate phase errors that depend on a temporal off-set between a reference point in time of the transmission of the signal by the transmitter and a value assumed and/or estimated for the evaluation for the reference point in time, said phase errors essentially mutually compensating each other across the symbol groups in the evaluation.

Abstract: A transmitter is configured to transmit signals each having a pilot sequence including a plurality of pilot sequence symbols, wherein the transmitter includes a signal generator, wherein the signal generator is configured to provide the pilot sequence starting from a base sequence which includes a plurality of base sequence symbols, wherein the signal generator provides the pilot sequence symbols starting from the base sequence symbol successively repeated R?1 times, and wherein R is a natural number greater than or equal to two, wherein the base sequence is configured such that a correlation of the pilot sequence with a transmission signal formed from the pilot sequence has a main maximum which is as narrow as possible and/or secondary maximums which are as small as possible.

Abstract: The present disclosure relates to reversal agents, which specifically bind to anti-Factor XI and/or anti-Factor XIa antibodies, and reverse one or more anticoagulant effects of the anti-Factor XI and/or anti-Factor XIa antibodies, as well as to methods of use thereof, such as methods for reversing anticoagulant effects of such anti-Factor XI and/or anti-Factor XIa antibodies, and to related methods for managing bleeding or bleeding risks.

Abstract: A drive device for an all-wheel drive, two-track motor vehicle, in the drive train of which a first motor vehicle axle and, via a center clutch, a second motor vehicle axle are driven permanently by a drive assembly in driving operation. In the closed state of the center clutch, the second vehicle axle is engaged with the drive train, and, in the open state of the clutch, the second vehicle axle is decoupled from the drive train. In a driving situation with engaged all-wheel drive as well as with axle friction coefficients of varying size, a greater wheel torque can be taken up at the vehicle axle with a large axle friction coefficient than at the vehicle axle with a small axle friction coefficient, and a control instrument is provided, which, for engine torque limitation, limits the drive assembly to a maximum allowed engine torque.

Abstract: A transmitter is configured to transmit at least one signal with a pilot sequence having a plurality of pilot symbols, wherein the transmitter has a signal generator, wherein the signal generator provides the pilot sequence, wherein the signal generator provides the pilot sequence such that the pilot sequence has at least two symbol groups each having at least two pilot symbols, and the symbol groups, when evaluating a signal received by a receiver as a result of the transmission of the signal with respect to a phase, the symbol groups generate phase errors that depend on a temporal off-set between a reference point in time of the transmission of the signal by the transmitter and a value assumed and/or estimated for the evaluation for the reference point in time, said phase errors essentially mutually compensating each other across the symbol groups in the evaluation.

Abstract: A transmitter is configured to transmit signals each having a pilot sequence including a plurality of pilot sequence symbols, wherein the transmitter includes a signal generator, wherein the signal generator is configured to provide the pilot sequence starting from a base sequence which includes a plurality of base sequence symbols, wherein the signal generator provides the pilot sequence symbols starting from the base sequence symbol successively repeated times, and wherein R is a natural number greater than or equal to two, wherein the base sequence is configured such that a correlation of the pilot sequence with a transmission signal formed from the pilot sequence has a main maximum which is as narrow as possible and/or secondary maximums which are as small as possible.

Abstract: The present invention is directed to a transgenic maize plant or a part thereof comprising as transgene a nucleic acid capable of expressing a cell wall invertase or a functional part thereof, preferably a Chenopodium rubrum cell wall invertase or a functional part thereof, wherein as a result of the expression of the cell wall invertase or a functional part thereof the transgenic maize plant exhibits an enhanced tolerance to abiotic stress and/or an increased yield, to a method of producing such transgenic maize plant, to method of enhancing the tolerance to abiotic stress of a maize plant and/or of increasing yield potential of a maize plant, to a nucleic acid capable of expressing a cell wall invertase or a functional part thereof, preferably a Chenopodium rubrum cell wall invertase or a functional part thereof, to a vector comprising such nucleic acid, the use of the nucleic acid or vector for enhancing the tolerance to abiotic stress of a maize plant, for increasing yield potential of a maize plant and/o

Abstract: The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI (“Factor XIa”), and pharmaceutical compositions and methods of treatment comprising the same.